GERON CORP
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
GERN$0.97-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(IN THOUSANDS, EXCEPT SHARE DATA)
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Gain (Loss) · Total Stockholders' Equity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount | ||||||||||
| Balance at December 31, 2024 | 606,387,666 | $606 | $2,051,794 | $(1,772,341) | $261 | $280,320 | ||||
| Net loss | — | — | — | (19,835) | — | (19,835) | ||||
| Other comprehensive loss | — | — | — | — | 55 | 55 | ||||
| Foreign currency translation adjustment | — | — | — | — | (12) | (12) | ||||
| Exercise of Pre-Funded Warrant | 30,369,830 | 31 | — | — | — | 31 | ||||
| Issuances of common stock under equity plans | 155,349 | 256 | — | — | 256 | |||||
| Stock-based compensation related to issuances of common stock and options for services | 4,913 | — | 15 | — | — | 15 | ||||
| Stock-based compensation for equity-based awards to employees and directors | — | — | 7,408 | — | — | 7,408 | ||||
| Balance at March 31, 2025 | 636,917,758 | $637 | $2,059,473 | $(1,792,176) | $304 | $268,238 | ||||
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Gain (Loss) · Total Stockholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance at December 31, 2023 | 544,912,215 | $545 | $1,844,988 | $(1,597,769) | $185 | $247,949 |
| Net loss | — | — | — | (55,390) | — | (55,390) |
| Other comprehensive income | — | — | — | — | (448) | (448) |
| Foreign currency translation adjustment | — | — | — | — | (10) | (10) |
| Issuance of common stock and pre-funded warrant to purchase common stock in public offering, net of issuance costs of $9,000 | 41,999,998 | 42 | 140,958 | — | — | 141,000 |
| Issuance of common stock in connection with exercise of warrants | 37,640 | — | 49 | — | — | 49 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 4,211,493 | 4 | 6,745 | — | — | 6,749 |
| Issuance of common stock under equity plans | 2,462 | — | 92 | — | — | 92 |
| Stock-based compensation for equity-based awards to employees and directors | — | — | 4,877 | — | — | 4,877 |
| Balance at March 31, 2024 | 591,163,808 | $591 | $1,997,709 | $(1,653,159) | $(273) | $344,868 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.